ATI Pathophysiology Quizlet Related

Review ATI Pathophysiology Quizlet related questions and content

A patient is taking raloxifene (Evista) for osteoporosis. What is the primary therapeutic effect of this medication?

  • A. It stimulates the formation of new bone.
  • B. It decreases bone resorption and increases bone density.
  • C. It increases the excretion of calcium through the kidneys.
  • D. It increases calcium absorption in the intestines.
Correct Answer: B

Rationale: The correct answer is B. Raloxifene, a selective estrogen receptor modulator (SERM), primarily works by decreasing bone resorption and increasing bone density. This mechanism of action helps in the prevention and treatment of osteoporosis by maintaining or improving bone strength. Choice A is incorrect because raloxifene does not directly stimulate the formation of new bone but rather helps in preserving existing bone. Choice C is incorrect because raloxifene does not increase the excretion of calcium through the kidneys; instead, it acts on bone tissue. Choice D is incorrect as raloxifene does not directly increase calcium absorption in the intestines but rather focuses on bone health.